Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Neural Transmission"
DOI: 10.1007/s00702-020-02235-6
Abstract: The SARS-CoV-2 virus pandemic has provoked drastic countermeasures including shutdowns of public services. We wanted to describe the effects of a 6 week shutdown of a large German botulinum toxin (BT) outpatient clinics on patients… read more here.
Keywords: therapy; sars cov; toxin therapy; botulinum toxin ... See more keywords
Botulinum Toxin Therapy of Social Anxiety Disorder: A Case Series.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000001066
Abstract: DISCUSSION Guanfacine may suppress rapid eye movement sleep, modulate sleep architecture, and can result in less sleepwalking. As a selective α-adrenergic 2A agonist, it has the ability to regulate glutamatergic and catecholamine systems, both implicated… read more here.
Keywords: guanfacine; toxin therapy; case; therapy social ... See more keywords